Can-Fite BioPharma Ltd.
CANF.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.86M
Close$
Share Statistics
| Market cap | $2.86 Million |
|---|---|
| Enterprise Value | $-79,297.00 |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -196.77% |
|---|---|
| Return on Assets | -118.60% |
| Return on Invested Capital | -166.93% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.2 |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.62 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Can-Fite Biopharma Ltd
5 employees
CEO: Pnina Fishman Can-Fite BioPharma Ltd. is an Israel-based, clinical-stage biopharmaceutical firm dedicated to developing small molecule therapeutic agents. Its research and development efforts are concentrated on addressing conditions such as cancer, v...